PUBLISHER: The Business Research Company | PRODUCT CODE: 1945254
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945254
Hand-held surgical instruments, typically crafted from premium stainless steel, encompass a diverse array of sizes, styles, and shapes tailored for various surgical procedures. These instruments are manually operated, held in hand during surgical procedures, and play a crucial role in ensuring precision and efficacy. The extensive range of hand-held surgical instruments includes scalpels, forceps, scissors, and retractors.
The primary product categories within hand-held surgical instruments consist of forceps, retractors, dilators, graspers, scalpels, and other specialized tools. Forceps, for instance, are employed to securely grasp, pull, or hold items, particularly in delicate surgical operations. This versatile two-bladed tool, featuring a handle, serves multiple functions, including managing sterile dressings and gripping tissues. Hand-held surgical instruments find applications in various surgical domains such as neurosurgery, cardiovascular procedures, orthopedics, plastic and reconstructive surgery, obstetrics, and gynecology. These instruments are utilized across a spectrum of healthcare settings, including hospitals, clinics, and ambulatory surgical centers, ensuring their indispensable role in the medical field.
Tariffs are impacting the hand-held surgical instruments market by increasing costs of imported stainless steel, precision components, coatings, and manufacturing equipment used in forceps, scalpels, and retractors. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported instruments, while Asia-Pacific faces export-related cost pressures. These tariffs are raising instrument prices and affecting replacement cycles. However, they are also encouraging local instrument manufacturing, regional supplier development, and innovation in cost-efficient surgical tool production.
The hand-held surgical instruments market research report is one of a series of new reports from The Business Research Company that provides hand-held surgical instruments market statistics, including hand-held surgical instruments industry global market size, regional shares, competitors with a hand-held surgical instruments market share, detailed hand-held surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the hand-held surgical instruments industry. This hand-held surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hand-held surgical instruments market size has grown rapidly in recent years. It will grow from $7.54 billion in 2025 to $8.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to expansion of surgical procedures across specialties, increasing hospital surgical volumes, availability of standardized stainless steel instruments, growth in ambulatory surgical centers, rising demand for reusable surgical tools.
The hand-held surgical instruments market size is expected to see rapid growth in the next few years. It will grow to $12.96 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing adoption of advanced surgical techniques, rising focus on infection prevention, expansion of outpatient surgical procedures, growing investments in surgical innovation, increasing demand for procedure-specific instruments. Major trends in the forecast period include increasing demand for precision surgical instruments, rising use of disposable and single-use instruments, growing adoption of ergonomic instrument designs, expansion of minimally invasive surgical tools, enhanced focus on instrument sterility and durability.
The rising prevalence of chronic diseases is expected to drive the growth of the handheld surgical instruments market in the coming years. Chronic diseases are long-term health conditions that persist over extended periods and generally require continuous medical management. Handheld surgical instruments play an important role in the management and treatment of chronic diseases by supporting diagnosis and evaluation, biopsy and tissue sampling, pain management, and procedures aimed at improving patient outcomes and quality of life. For example, in January 2023, according to the National Center for Biotechnology Information (NCBI), part of the US National Library of Medicine, projections indicate that by 2050 the number of individuals aged 50 years and older living with at least one chronic illness will increase to between 99.5 million and 142.66 million. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the handheld surgical instruments market.
Leading companies in the hand-held surgical instruments market are strategically emphasizing product innovation, exemplified by offerings like the Sunoptic Surgical Light Wand, to fortify their market standing. The Sunoptic Surgical Light Wand is a single-use, sterile, pre-packaged light source designed to illuminate incision sites internally. This innovative solution not only ensures excellent lighting in surgical rooms but also presents an affordable light source for hospitals and clinics. In June 2023, SURE Retractors Inc., a UK-based medical device company, introduced the Sunoptic Surgical Light Wand with an LED light tailored to illuminate deep surgical cavities, eliminating shadows, reducing eye strain during prolonged treatments, and enhancing visibility for surgical procedures. The product boasts a 90-minute guaranteed strong LED light, eliminating the need for additional headlamps or external light sources.
In August 2023, STERIS PLC, an Ireland-based medical equipment provider, successfully acquired surgical instrumentation assets from Becton, Dickinson, and Company, a US-based medical technology company. The acquisition, executed for an undisclosed amount, bolsters STERIS's position by enhancing, complementing, and expanding its product portfolio within the healthcare segment. The acquired assets encompass surgical instrumentation, laparoscopic instrumentation, and sterilization container assets, marking a significant development in STERIS's growth trajectory. Becton, Dickinson, and Company, known for its diverse offerings including medical devices, reagents, and surgical instruments, has strategically contributed to STERIS's product expansion in the competitive healthcare market.
Major companies operating in the hand-held surgical instruments market are Johnson & Johnson, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., KLS Martin Group, Aspen Surgical Products Inc., CooperSurgical Inc., Thompson Surgical Instruments Inc., Becton Dickinson and Company, Swann-Morton Limited, Peters Surgical SAS, Huaiyin Medical Instruments Co. Ltd., ConMed Corp., Stryker Corporation, Integra LifeSciences Corporation, Smith & Nephew plc, Aesculap AG, Scanlan International Inc., Sklar Surgical Instruments, Symmetry Surgical Inc., Millennium Surgical Corp., Surgipro Inc., Wexler Surgical, Grena Ltd., Surgmed Group, Surtex Instruments Ltd., Instrumed International B.V., Surgitrac Instruments UK Limited, Sontec Instruments Inc.
North America was the largest region in the hand-held surgical instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hand-held surgical instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hand-held surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hand-held surgical instruments market consists of sales of cannulas, dermatome, and trocars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hand-Held Surgical Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hand-held surgical instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hand-held surgical instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hand-held surgical instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.